Topic: Medicaid

Generic drugmakers criticize U.S. health plan rebates

WASHINGTON (Reuters) - The U.S. government could save more money by increasing the use of cheaper generic drugs rather than hiking rebates paid by manufacturers, an industry executive said on Thursday. A healthcare reform plan proposed by Senate Finance Committee Chairman Max ...
AP IMPACT: Medicaid pays millions for drugs not reviewed for safety and effectivenessThe government is paying millions for risky medications that have never been reviewed for safety and effectiveness but are still covered under Medicaid, an Associated Press analysis of federal data ...
AP IMPACT: Medicaid pays millions for drugs not reviewed for safety and effectivenessTaxpayers have shelled out at least $200 million since 2004 for medications that have never been reviewed by the government for safety and effectiveness but are still covered under Medicaid, ...